The Future of Precision Medicine in Glaucoma Management: Genetic Insights and Personalized Approaches
Published 2025-04-09
Keywords
- glaucoma, precision medicine, genetics, biomarkers, personalized treatment, intraocular pressure, genetic predisposition, therapeutic interventions
How to Cite
Abstract
Glaucoma is a leading cause of irreversible blindness worldwide, and its management
remains a challenge due to the heterogeneity of the disease and varying responses to
treatment. Traditional approaches to glaucoma care focus on intraocular pressure (IOP)
reduction, but they do not always account for the genetic and molecular underpinnings that
contribute to the disease’s progression. With the advent of precision medicine, there is a
growing recognition of the potential for genetic insights to revolutionize glaucoma
management. This paper explores the role of genetics in glaucoma pathogenesis and its
integration into personalized approaches for treatment. By investigating current
advancements in genetic research, biomarkers, and targeted therapies, we assess the future
prospects of precision medicine in improving patient outcomes in glaucoma care.